Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-10
2011-10-18
Kosar, Andrew D (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S281000
Reexamination Certificate
active
08039476
ABSTRACT:
The present invention relates to a novel polymorph of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]-phenyl}-N-methyl-acetamide, processes for its preparation, its use as a medicament, its use in the manufacture of a medicament, and pharmaceutical compositions comprising the novel polymorph.
REFERENCES:
patent: 6399621 (2002-06-01), Dusza et al.
patent: WO-01/15700 (2001-03-01), None
patent: WO-2004/018476 (2004-03-01), None
patent: WO-2006/044903 (2006-04-01), None
patent: WO 2006/136530 (2006-12-01), None
patent: WO-2006-136530 (2006-12-01), None
Threlfall, T. L., et al. “Analysis of Organic Polymorphs”, The Analyst, vol. 120, Oct. 1995, pp. 2435-2460. XP-009026967.
Anglada Luis
Guglietta Antonio
Palomer Albert
Birch & Stewart Kolasch & Birch, LLP
Ferrer Internacional S.A.
Kosar Andrew D
Leeser Erich A
LandOfFree
Polymorph B of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymorph B of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorph B of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4271769